SCHEMBL22022211

SCHEMBL22022211

COc1ccc(-c2cc3cc(Cl)ccc3n2Sc2cc(Br)cc(Cl)c2O)cc1

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ACLY P53396 19/20 0.62
▸ CCR2 P41597 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22021612 0.79 ACLY (0.46) ACLY
SCHEMBL29985338 0.77 ACLY (1.00) ACLY
SCHEMBL21961934 0.77 ACLY (1.00) ACLY
SCHEMBL22021620 0.70 ACLY (0.50) ACLYCCR2
SCHEMBL1637774 0.68 ACLY (0.53) ACLYCCR2
SCHEMBL22005071 0.67 ACLY (0.47) ACLYCCR2
SCHEMBL21954763 0.65 ACLY (1.00) ACLY
SCHEMBL21954759 0.65 ACLY (1.00) ACLY
SCHEMBL21954738 0.62 ACLY (1.00) ACLY
SCHEMBL11814974 0.59 GRIK1 (0.42) ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020102616-A1 ACLY INHIBITORS AND USES THEREOF Nimbus Artemis, Inc. (US) 2020-05-22 — — WO disclosed
Send feedback